| [1] |
Shaw JE,Sicree RA,Zimmet PZ.Global estimates of the prevalence of diabetes for 2010 and 2030[J].Diabetes Res Clin Pract,2010,87(1):4-14.
|
| [2] |
Engelgau MM,Geiss LS,Saaddine JB,et al.The evolving diabetes burden in the United States[J].Ann Intern Med,2004,140(11):945-950.
|
| [3] |
Kudo T,Shimada T,Toda T,et al.Altered expression of CYP in TSOD mice:a model of type 2 diabetes and obesity[J].Xenobiotica,2009,39(12):889-902.
|
| [4] |
Kim YC,Oh EY,Kim SH,et al.Pharmacokinetics and pharmacodynamics of intravenous to rasemide in diabetic ratsinduced by alloxan or streptozotocin[J].Biopharm Drug Dispos,2005,26(8):371-378.
|
| [5] |
Miura T,Ueda N,Yamada K,et al.Antidiabetic effects of corosolic acid in KK-Ay diabetic mice[J].Biol Pharm Bull,2006,29(3):585-587.
|
| [6] |
Srinivasan K,Viswanad B,Asrat L,et al.Combination of high-fat diet-fed and low-dose streptozotocin-treated rat:a model for type 2 diabetes and pharmacological screening[J].Pharmacol Res,2005,52(4):313-320.
|
| [7] |
Liu Q,Zhao D,Chen X,et al.Determination of corosolic acid,a natural potential anti-diabetes compound in rat plasma by high-performance liquid chromatography-mass spectrometry and its application to pharmacokinetic and bioavailability studies[J].Planta Med,2011,77(15):1 707-1 711.
|
| [8] |
Lehr T,Staab A,Tillmann C,et al.A quantitative enterohepatic circulation model:development and evaluation with tesofensine and meloxicam[J].Clin Pharmacokinet,2009,48(8):529-542.
|
| [9] |
Salgin B,Ong KK,Thankamony A,et al.Higher fasting plasma free fatty acid levels are associated with lower insulin secretion in children and adults and a higher incidence of type 2 diabetes[J].J Clin Endocrinol Metab,2012,97(9):3 302-3 309.
|
| [10] |
CohenMP,Ziyadeh FN,Chen S.Amadori-modified glycated serum proteins and accelerated atherosclerosis in diabetes:pathogenic and therapeutic implications[J].J Lab Clin Med,2006,147(5):211-219.
|
| [11] |
Prashanth M,Ganesh HK,Vima MV,et al.Prevalence of nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus[J].J Assoc Physicians India,2009,57:205-210.
|
| [12] |
Zhuo L,Zou G,Li W,et al.Prevalence of diabetic nephropathy complicating non-diabetic renal disease among Chinese patients with type 2 diabetes mellitus[J].Eur J Med Res.2013,18(1): 4-11.
|
下载:
